Home > Insider Trading > Filing (0001441844-11-000013)

Filing Details

Accession Number:: 0001441844-11-000013
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2011-04-05 09:48:12
Reporting Period:: 2011-04-01

Filing Date:: 2011-04-05
Accepted Time:: 2011-04-05 09:48:12
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
835887	Progenics Pharmaceuticals Inc	PGNX	Pharmaceutical Preparations (2834)	133379479

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1250274	J Robert Israel	777 Old Saw Mill River Road Tarrytown NY 10591	Sr. Vp, Medical Affairs	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2011-04-01	1,000	$5.33	44,377	No	4	M	Direct
Common Stock	Disposition	2011-04-01	1,000	$6.33	43,377	No	4	S	Direct
Common Stock	Acquisiton	2011-04-01	3,332	$5.05	46,953	No	4	M	Direct
Common Stock	Disposition	2011-04-01	2,913	$6.29	44,040	No	4	F	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	F	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	ESPP (right to buy)	Disposition	2011-04-01	3,332	$0.00	3,332	$5.05
Common Stock	ESPP (right to buy)	Acquisiton	2011-04-01	2,872	$0.00	2,872	$6.18
Common Stock	Non-Qualified Stock Option (right to buy)	Disposition	2011-04-01	1,000	$0.00	1,000	$5.33

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0	2011-04-01	2011-04-01	No	4	M	Direct
2,872	2011-10-01	2011-10-01	No	4	A	Direct
40,000	2011-04-01	2019-07-01	No	4	M	Direct

Footnotes

The Reporting Person is exercising options under this grant in pre-established increments under and in accordance with provisions of a previously established Plan of Sale under Rule 10b5-1, which was established in accordance with the policies and procedures of the Issuer.
Acquired upon the complete exercise of a grant under the Non-Qualified Employee Stock Purchase Plan, which grant was previously reported at the start of a six month option term, to acquire common stock up to an option amount which is 25% of the optionee's quarterly salary less $6,250, at a purchase price equal to the lower of 100% of the market value on the date of grant or 85% of the market value on the date of exercise.
Includes shares of common stock acquired from the non-reportable exercise of a Grant under the Qualified Employee Stock Purchase Plan.
Granted under the Company's Non-Qualified Employeee Stock Purchase Plan.
The option was granted on the first day of the option term and previously reported as a right to purchase shares of the Company's common stock at an exercise price equal to the market value on the date of grant. In accordance with the Non-Qualified Employee Stock Purchase Plan, the option is ultimately exercisable for an exercise price which is the lower of 100% of the market value on the grant date or 85% of the market value on the exercise date. The number of shares acquired upon exercise is based on the option amount divided by the lower of 100% of the market value on the grant date or 85% of the market value on the exercise date.
The option will be exercisable for that number of shares equal to the option amount (25% of the optionee's quarterly salary less $6,250) divided by the lesser of the market value of the common stock on the grant date or 85% of the market value on the exercise date.